# Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults

> **NCT00790881** · PHASE4 · COMPLETED · sponsor: **University of Cape Town** · enrollment: 36 (estimated)

## Conditions studied

- Malaria
- HIV

## Interventions

- **DRUG:** Artemether/Lumefantrine
- **DRUG:** Artemether/ lumefantrine

## Key facts

- **NCT ID:** NCT00790881
- **Lead sponsor:** University of Cape Town
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-08
- **Final completion:** 2009-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2010-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00790881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00790881, "Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00790881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*